Smith & Nephew (SNN) Long-Term Investments (2009 - 2025)

Smith & Nephew (SNN) posted quarterly Long-Term Investments of $121.0 million for Q4 2025, up 1628.57% year-on-year from $7.0 million in Q4 2024, and up 1628.57% on a QoQ basis from $7.0 million in Q2 2025.

Smith & Nephew (SNN) Long-Term Investments (2009 - 2025) Analysis & Trends

Smith & Nephew (SNN) has reported Long-Term Investments for 17 consecutive years, with $121.0 million the latest figure, recorded in Q4 2025.

  • Quarterly Long-Term Investments rose 1628.57% year-over-year to $121.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $121.0 million (up 1628.57% YoY) and the FY2025 annual result came in at $121.0 million, up 1628.57% from the prior year.
  • Long-Term Investments grew to $121.0 million in Q4 2025 per SNN's latest filing, from $7.0 million in the prior quarter.
  • Over the last five years, Long-Term Investments for SNN reached as high as $188.0 million in Q4 2021 and fell as low as $7.0 million in Q4 2024.
  • A 5-year average of $57.1 million and a median of $16.0 million in 2023 frame the typical range for Long-Term Investments.
  • Annual changes were most pronounced in 2022 — Long-Term Investments tumbled 75.53% — and 2025, when it surged 1628.57%.
  • Year by year, Long-Term Investments stood at $188.0 million in 2021, then slumped by 75.53% to $46.0 million in 2022, then slumped by 65.22% to $16.0 million in 2023, then plunged by 56.25% to $7.0 million in 2024, then jumped by 1628.57% to $121.0 million in 2025.
  • According to Business Quant data, Long-Term Investments over the past three periods registered $121.0 million, $7.0 million, and $7.0 million for Q4 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 1.09 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 285.60 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 166.25 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -
9 Smith & Nephew 25.80 Bn 25.22 Bn - 121.00 Mn
10 Steris 20.59 Bn 20.16 Bn 697.10 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 121.00 Mn
Jun 28, 2025 7.00 Mn
Dec 31, 2024 7.00 Mn
Jun 29, 2024 15.00 Mn
Dec 31, 2023 16.00 Mn
Dec 31, 2022 46.00 Mn
Dec 31, 2021 188.00 Mn
Dec 31, 2020 108.00 Mn
Jun 30, 2020 10.00 Mn
Dec 31, 2019 103.00 Mn
Jun 29, 2019 9.00 Mn
Dec 31, 2018 105.00 Mn
Jun 30, 2018 21.00 Mn
Dec 31, 2017 118.00 Mn
Dec 31, 2016 112.00 Mn
Dec 31, 2015 -25.00 Mn
Jun 30, 2015 13.00 Mn
Dec 31, 2014 -2.00 Mn
Sep 30, 2014 2.00 Mn
Jun 28, 2014 2.00 Mn